Bayesian Capital Management’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-47,600
| Closed | -$167K | – | 838 |
|
|
2024
Q2 | $167K | Buy |
+47,600
| New | +$167K | 0.02% | 622 |
|
|
2024
Q1 | – | Sell |
-20,300
| Closed | -$34.5K | – | 923 |
|
|
2023
Q4 | $34.5K | Buy |
+20,300
| New | +$34.5K | ﹤0.01% | 686 |
|
|
2022
Q4 | – | Sell |
-44,600
| Closed | -$188K | – | 881 |
|
|
2022
Q3 | $188K | Buy |
+44,600
| New | +$188K | 0.04% | 527 |
|
|
2020
Q2 | – | Sell |
-12,600
| Closed | -$148K | – | 624 |
|
|
2020
Q1 | $148K | Buy |
+12,600
| New | +$148K | 0.03% | 625 |
|